One-carbon Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth servicesManufacturing
Business model:B2B
one-carbon Therapeutics is a Swedish company specialized in targeting proteins involved in one-carbon metabolism and DNA damage and repair (DDR) as a way of inducing cancer cell death.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 16.07M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to One-carbon Therapeutics
| Name | Criteria | |
|---|---|---|
 |
CatalYm
58%
|
|
 |
Inbrain Neuroelectronics
58%
|
|
 |
InnovaFeed SAS
58%
|
|
 |
Memo Therapeutics
58%
|
|
|
Peptomyc
58%
|
|
 |
Peptone
58%
|
|
 |
Salvia BioElectronics
58%
|
|
 |
Sarcura
58%
|
|
|
Synendos Therapeutics
58%
|
|
|
EG 427
58%
|
|
Belgium
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal